Veterinary Medicines

ADiuvant -SUIVAX – Vaccino liofilizzato e diluente per emulsione iniettabile

Authorised
  • Aujeszky's disease virus, strain LomBart gE-, Live
Download as PDF

Product identification

Medicine name:
ADiuvant -SUIVAX – Vaccino liofilizzato e diluente per emulsione iniettabile
Active substance:
  • Aujeszky's disease virus, strain LomBart gE-, Live
Target species:
  • Pig (for fattening)
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Aujeszky's disease virus, strain LomBart gE-, Live
    5.50
    log10 tissue culture infective dose 50
    /
    2.00
    millilitre(s)
Pharmaceutical form:
  • Lyophilisate for emulsion for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Pig (for fattening)
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI09AD01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Italy
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Fatro S.p.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Fatro S.p.A.
Responsible authority:
  • Ministry Of Health
Authorisation number:
  • 104392
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Italian (PDF)
Published on: 3/06/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."